Figure 3

X-ray diffractograms of (a) pure gliclazide, (b) optimized formulation, SGNCF1; DSC thermograms of (c) pure gliclazide, (d) physical mixture and (e) optimized formulation, SGNCF1; (f) FTIR spectra of pure gliclazide, PLGA, Poloxamer 188, physical mixture and optimized formulation, SGNCF1.